Sunday, January 3, 2021

Covaxin clinical trials cross 23,000 subjects

https://ift.tt/eA8V8J

Bharat Biotech on Saturday announced successful recruitment of 23,000 volunteers and continued progress towards achieving the goal of 26,000 participants for Phase-3 clinical trial of Covaxin across multiple sites in India.



from https://www.thetimesofbengal.com/covaxin-clinical-trials-cross-23000-subjects/
via The Times of Bengal | An exclusive 24*7 daily news portal RSS Feed

No comments:

Post a Comment